期刊文献+

温阳振衰颗粒治疗慢性肾功能衰竭(阳虚证)的临床研究 被引量:11

Influence of Wenyang Zhenshuai Decoction on the Clinical Efficacy on Patients with Chronic Renal Failure of Yang Deficiency Type
下载PDF
导出
摘要 目的观察温阳振衰颗粒对慢性肾功能衰竭患者临床疗效及血清结缔组织生长因子(CTGF)、转化生长因子-β1(TGF-β1)的影响。方法将患者60例按随机数字表法分为对照组和观察组各30例,对照组给予西医常规基础治疗,观察组在此基础上给予温阳振衰颗粒治疗,两组患者均接受8周的治疗。观察两组的疗效,比较治疗前后肌酐清除率(Ccr)、血肌酐(Scr)、尿素氮(BUN)、血清CTGF、TGF-β1的水平。结果观察组综合疗效、中医症候疗效总有效率明显高于对照组(P<0.05);治疗后,观察组血清CTGF、TGF-β1明显低于对照组(P<0.01);观察组的Ccr、Scr、BUN亦明显低于对照组(P<0.05)。结论温阳振衰颗粒可明显改善慢性肾功能衰竭患者的肾纤维化,对慢性肾功能衰竭有较好的疗效。 Objective: To investigate the therapeutic effects of Wenyang Zhenshuai Decoction on serum CTGF and TGF-β1 and its clinical effects on chronic renal failure. Methods: 60 eases were randomly divided into the control group and the observation group, 30 cases in each group. The control group was given routine treatment of Western medicine,white the observation group was given Wenyang Zhenshuai Decoction on the basis. Patients were treated for 8 weeks. The curative effects of the two groups were observed. The levels of Ccr,Scr,BUN ,serum CTGF and TGF-β1 in the two groups before and after treatment were compared. Results: The effective rate of the observation group was significantly higher than that of the control group (P〈 0.05 ). After treatment, the serum CT- GF and TGF-β1 of the observation group were significantly lower than those of the control group (P 〈 0.01 ). There was no difference between the two groups before treatment,but after treatment,Ccr,Scr and BUN of the observa- tion group were significantly lower than those in the control group (P〈 0.05). Conclusion: Wenyang Zhenshuai Decoction can substantially improve renal fibrosis of chronic renal failure patients,so it has a good therapeutic ef- fect in chronic renal failure.
出处 《中国中医急症》 2018年第2期202-204,211,共4页 Journal of Emergency in Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81704061) 湖南省研究生科研创新项目(CX2017B433)
关键词 温阳振衰颗粒 慢性肾功能衰竭CTGF TGF-βl Wenyang Zhenshuai Decoction Chronic renal failure CTGF TGF-β1
  • 相关文献

参考文献1

二级参考文献8

  • 1National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis 2000,(Suppl 2) 35: S1 - S140
  • 2Aparicio M, Chauveau P, Combe C. Are supplemented low -protein diets nutritionally safe? Am J Kidney Dis 2001, 37 ( 1 Suppl 2) :S71 -76
  • 3Mitch W E. Are supplements of ketoacids and amino acids useful in treating patients with chronic renal failure? Wien Klin Wochenschr 2000,112:863-4
  • 4Levey AS, Greene T, Beck GJ, et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? J Am Soc Nephrol 1999, 10:2426 - 39
  • 5Kopple JD. Dietary protein and energy requirements in ESRD patients. Am J Kidney Dis 1998, 32:(6 Suppl 4)S97 - 104
  • 6American Diabetes Association, Position Statements Diabetic Nephropathy. Diabetes Care 2003, 26: S94 - S98
  • 7Lara Pupim, Cathi Jackson Martin, T. Alp Ikizler. Assessment of protein - Energy nutritional Status. In: Kopple JD, Massry SG (eds). Nutritional Management of Renal Disease. (2nd edition) Wliiiams & Wilkins 2003:223-241
  • 8Denis Fougue. Influence of Dietary Protein Intake on the Progres sion of Chronic Renal Insufficiency. In: Kopple JD, Massry SG (eds). Nutritional Management of Renal Disease. (2nd edition )Wliiiams& Wilkins 2003:241- 261

共引文献24

同被引文献138

引证文献11

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部